Beam Therapeutics (BEAM) Other Accumulated Expenses (2020 - 2026)
Beam Therapeutics (BEAM) reported Other Accumulated Expenses of $9.06 million for Q2 2026, up 304.7% from $2.24 million a year earlier but down 1.1% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Beam Therapeutics posted Other Accumulated Expenses of $1.99 million, down 74.6% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of -14.0% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $7.81 million in FY2024 (-72.7%), $28.64 million in FY2023 (+133.6%), $12.26 million in FY2022 (+76.1%) and $6.96 million in FY2021 (+64.7%).
- Five-year quarterly Other Accumulated Expenses spans a low of $1.99 million in Q4 2025 and a high of $28.64 million in Q4 2023.
- Year over year, Other Accumulated Expenses gained in three of the last eight quarters, with growth averaging 13.2%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q2 2026 (growth of 304.7%); the low point was Q2 2025 (a decline of 90.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $9.16 million (Q1 2026), $1.99 million (Q4 2025) and $2.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.06 Mn |
| Mar 31, 2026 | 9.16 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 7.81 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 23.54 Mn |
| Mar 31, 2024 | 27.05 Mn |
| Dec 31, 2023 | 28.64 Mn |
| Sep 30, 2023 | 4.78 Mn |
| Jun 30, 2023 | 7.52 Mn |
| Mar 31, 2023 | 11.10 Mn |
| Dec 31, 2022 | 12.26 Mn |
| Sep 30, 2022 | 13.09 Mn |
| Jun 30, 2022 | 10.03 Mn |
| Mar 31, 2022 | 4.91 Mn |
| Dec 31, 2021 | 6.96 Mn |
| Sep 30, 2021 | 5.12 Mn |
API Access
Beam Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();